Nifty Pharma logo

Nifty Pharma

NSESector20 companies

P/E
39.18
P/B
4.77
Dividend yield
0.59%
1M
−6.71%
3M
−1.26%
1Y
+12.67%

P/E against its own past

Where today's P/E sits among every trading day of each window: the dot is today, the tick the middle day.

P/E at each month's last trading day, and on 23 Oct 2026

What the Nifty Pharma companies earned

Each quarter against the same quarter a year earlier, added up over today's members that filed both. A quarter fewer than 60% of them filed is left out.

Revenue growth
+15.3%quarter to Jun 2026
Profit growth
+6.0%quarter to Jun 2026
Filed the quarter
20of 20
Median ROCE
15.8%year to Mar 2026

Growth against the same quarter a year earlier, per cent

  • Revenue growth
  • Profit growth
  • Loss
Revenue grew against a year earlier in 12 of the 12 quarters shown.Fastest profit growth +48.5%, quarter to Mar 2024.

The largest companies

The 12 largest companies in the Nifty Pharma, each sized by its market cap.

Market cap, ₹ crore

  • Sun Pharmaceutical Industries₹4,19,404 Cr
  • Divi's Laboratories₹2,37,594 Cr
  • Torrent Pharmaceuticals₹1,72,094 Cr
  • Zydus Lifesciences₹1,12,658 Cr
  • Cipla₹1,08,093 Cr
  • Laurus Labs₹1,06,442 Cr
  • Dr. Reddy's Laboratories₹1,02,624 Cr
  • Mankind Pharma₹91,390 Cr
  • Aurobindo Pharma₹90,432 Cr
  • Lupin₹88,207 Cr
  • Glenmark Pharmaceuticals₹61,147 Cr
  • Alkem Laboratories₹59,149 Cr

Companies in the Nifty Pharma

Largest first, by market cap.

Funds that follow the Nifty Pharma

2 funds with the Nifty Pharma as the benchmark they measure themselves against, from each fund's latest monthly report.

About the Nifty Pharma

An index of 20 companies: it shows how they have moved together, and its P/E is what the market pays for a year of their profit.

Published by
NSE
Kind
Sector
Companies
20
List last changed
8 Sep 2026
Above 200-day average
11 of 20